Related Experiment Videos
Peptide nucleic acid delivery to human mitochondria
P F Chinnery1, R W Taylor, K Diekert
1Department of Neurology, The University of Newcastle upon Tyne, UK.
Gene Therapy
|January 19, 2000
Summary
Biotinylated peptide nucleic acids (PNAs) can enter human cells and be directed to specific locations like the nucleus or mitochondria. This targeted delivery shows promise for PNA-based gene therapies.
Area of Science:
- Molecular Biology
- Biochemistry
- Genetics
Background:
- Peptide nucleic acids (PNAs) are synthetic molecules with high affinity for DNA and RNA.
- Efficient cellular uptake and sub-cellular trafficking are crucial for PNA-mediated gene therapy but are poorly understood.
- Targeting specific organelles, like mitochondria, is essential for treating mitochondrial DNA (mtDNA) diseases.
Purpose of the Study:
- To investigate the cellular uptake and sub-cellular localization of biotinylated PNAs.
- To determine if PNAs can be directed to the mitochondrial matrix for potential mtDNA disease therapy.
Main Methods:
- Utilized fluorescence confocal microscopy to study PNA uptake in cultured human myoblasts.
- Investigated the import of peptide-PNA conjugates into isolated mitochondria in vitro.
- Confirmed PNA delivery to mitochondria in intact cells using confocal microscopy.
Main Results:
- Biotinylated PNAs were taken up by human myoblasts, initially showing punctate staining, then cytosolic release, and finally nuclear localization.
- PNAs attached to a mitochondrial targeting peptide (cytochrome c oxidase subunit VIII presequence) were successfully imported into isolated mitochondria.
- Confocal microscopy confirmed the delivery of peptide-PNA conjugates to mitochondria within intact cells.
Conclusions:
- Biotinylated PNAs can efficiently cross cell membranes and be directed to specific sub-cellular compartments.
- The targeted delivery of PNAs to mitochondria is feasible, highlighting their potential for human gene therapy, particularly for mtDNA disorders.